UJB Performance — ProShares Ultra High Yield
Data updated: 2026-08-14
UJB returned +1.40% year to date and +9.36% over one year to May 2026. Annualised returns are +12.50% over 3 years and +3.22% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $142, against $173 for the category, and to $109 over one year, against $137. Volatility over the past three years was 9.16% a year. In the 12 months to May 2026 the fund lost a net $9.9M, and assets reached $8.68M.
UJB Growth of $100
What $100 invested in ProShares Ultra High Yield grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | UJB | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $109 | $137 |
| 3 years (Jun 2023 – May 2026) | $142 | $173 |
| 5 years (Jun 2021 – May 2026) | $117 | $155 |
| Since data start (Sep 2019 – May 2026) | $132 | $181 |
UJB Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.40% |
| 1 year | +9.36% |
| 3 years (annualised) | +12.50% |
| 5 years (annualised) | +3.22% |
UJB Annual Returns
Calendar-year total returns of ProShares Ultra High Yield, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +1.40% |
| 2025 | +12.06% |
| 2024 | +9.58% |
| 2023 | +17.64% |
| 2022 | −23.29% |
| 2021 | +6.39% |
| 2020 | +5.30% |
| 2019 (Sep–Dec) | +5.10% |
UJB Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.9% | −0.3% | −2.3% | +2.7% | +0.5% | — | — | — | — | — | — | — |
| 2025 | +2.3% | +1.5% | −2.6% | −0.3% | +3.1% | +3.3% | −0.2% | +1.8% | +1.4% | −0.5% | +1.2% | +0.6% |
| 2024 | −0.2% | +0.1% | +1.7% | −3.2% | +2.7% | +0.5% | +4.2% | +2.4% | +2.9% | −2.4% | +2.8% | −2.0% |
| 2023 | +7.0% | −4.2% | +3.3% | 0.0% | −2.9% | +3.1% | +1.9% | −0.1% | −3.6% | −2.5% | +9.4% | +6.0% |
| 2022 | −5.4% | −1.8% | −2.7% | −8.3% | +3.2% | −13.9% | +13.7% | −8.7% | −7.7% | +6.2% | +6.5% | −3.9% |
| 2021 | −0.9% | −0.6% | +2.3% | +1.2% | 0.0% | +2.6% | +0.1% | +1.1% | −0.8% | −0.7% | −2.4% | +4.5% |
| 2020 | −1.1% | −2.7% | −20.4% | +9.2% | +5.9% | −1.3% | +10.4% | −0.1% | −2.0% | +0.7% | +6.7% | +3.8% |
| 2019 | — | — | — | — | — | — | — | — | +0.7% | −0.2% | +1.0% | +3.6% |
UJB Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 9.16%
- 3-year Sharpe ratio: 0.87 (vs 4.5% risk-free rate)
- Best month: +9.42% (Nov 2023)
- Worst month: −3.55% (Sep 2023)
UJB Fund Flows
Monthly money in and out of ProShares Ultra High Yield, from SEC Form N-PORT.
- 12-month net flow: −$9.9M
- 12-month gross sales (incl. reinvestments): $125.7M
- Sales ÷ redemptions: 0.93×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $11.0M | $16.4M | −$5.4M |
| Apr 2026 | $27.2M | $18.1M | $9.1M |
| Mar 2026 | $0 | $15.9M | −$15.9M |
| Feb 2026 | $10.4M | $3.2M | $7.2M |
| Jan 2026 | $8.8M | $2.4M | $6.4M |
| Dec 2025 | $11.0M | $15.8M | −$4.8M |
| Nov 2025 | $3.9M | $10.9M | −$6.9M |
| Oct 2025 | $15.0M | $779K | $14.2M |
| Sep 2025 | $794K | $20.3M | −$19.5M |
| Aug 2025 | $21.0M | $3.8M | $17.1M |
| Jul 2025 | $11.5M | $13.0M | −$1.5M |
| Jun 2025 | $5.2M | $15.1M | −$9.9M |
UJB Assets Under Management
Net assets of ProShares Ultra High Yield by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $8.68M |
| 2026-02-28 | $20.65M |
| 2025-11-30 | $11.82M |
| 2025-08-31 | $24.16M |
| 2025-05-31 | $17.92M |
| 2025-02-28 | $16.53M |
| 2024-11-30 | $23.08M |
| 2024-08-31 | $8.75M |
| 2024-05-31 | $7.53M |
| 2024-02-29 | $14.29M |
| 2023-11-30 | $23.97M |
| 2023-08-31 | $24.71M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.